Study guide

18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments

Key Takeaways Explain This Topic AI

Morbid obesity (BMI ≥ 40 kg/m²) exponentially reduces Functional Residual Capacity (FRC) primarily through severe depletion of Expiratory Reserve Volume (ERV), predisposing patients to rapid arterial oxygen desaturation during apnea due to concurrent elevations in basal metabolic oxygen consumption (VO₂).

Obesity Hypoventilation Syndrome (OHS / Pickwickian syndrome) is defined by the triad of obesity (BMI > 30 kg/m²), daytime hypercapnia (awake PaCO₂ > 45 mmHg), and sleep-disordered breathing; it is associated with severe pulmonary hypertension, cor pulmonale, and blunted central hypercapnic ventilatory drive.

The STOP-Bang score stratifies OSA risk across 8 criteria (Snoring, Tired, Observed apnea, high blood Pressure, BMI > 35, Age > 50, Neck circumference > 40 cm, Gender male); a score ≥ 5 indicates high OSA risk and mandates perioperative CPAP, opioid-sparing techniques, and heightened respiratory vigilance.

Anesthetic drug dosing requires precise weight metric selection: Succinylcholine (1.0-1.5 mg/kg) and Sugammadex (2, 4, or 16 mg/kg) are dosed on Total Body Weight (TBW); Induction Propofol, Remifentanil, and Opioids are dosed on Lean Body Weight (LBW); Non-depolarizing neuromuscular blockers (Rocuronium, Vecuronium, Cisatracurium) are dosed on Ideal Body Weight (IBW).

Optimal airway management requires the ramped / HELP position (Head-Elevated Laryngoscopy Position) to align the external auditory meatus with the sternal notch horizontally, preoxygenation with CPAP/PEEP, lung-protective mechanical ventilation based on IBW (6-8 mL/kg IBW with PEEP 8-12 cmH₂O), and mandatory awake extubation in a semi-recumbent/sitting position once TOF ratio ≥ 0.9 is confirmed.

Last updated: August 2026

18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments

Managing the morbidly obese patient requires an in-depth understanding of altered respiratory mechanics, hemodynamic strain, altered pharmacokinetics, and difficult airway anatomy. Anesthesia providers must apply precise weight scalars for pharmacologic agents, implement specialized preoxygenation and positioning techniques, and remain vigilant for sleep-disordered breathing syndromes.

1. Classification of Obesity & Weight Metrics

Body Mass Index (BMI) categorizes the degree of excess adiposity: BMI = Weight (kg) [ Height (m) ] 2 \text{BMI} = \frac{\text{Weight (kg)}}{[\text{Height (m)}]^2} BMI = [ Height (m) ] 2 Weight (kg) ​ +---------------------------------------------------------------------------------------------------------+

  • | WHO OBESITY CLASSIFICATION |
  • +-----------------------+---------------------+-----------------------------------------------------------+
  • | Classification | BMI Range (kg/m²) | Clinical & Cardiopulmonary Implications |
  • +-----------------------+---------------------+-----------------------------------------------------------+
  • | **Underweight** | < 18.5 | Frailty, malnutrition, reduced drug binding proteins |
  • | **Normal Weight** | 18.5 - 24.9 | Standard baseline physiologic parameters |
  • | **Overweight** | 25.0 - 29.9 | Modest increase in cardiovascular risk |
  • | **Class I Obesity** | 30.0 - 34.9 | Mild reduction in FRC and ERV |
  • | **Class II Obesity** | 35.0 - 39.9 | Significant reduction in chest wall compliance, OSA risk |
  • | **Class III Obesity** | **≥ 40.0** | **Morbid Obesity:** Marked V/Q mismatch, severe FRC loss |
  • | **Super-Obese** | **≥ 50.0** | Extreme risk for difficult mask/intubation, OHS, and PAH |
  • | **Super-Super Obese** | **≥ 60.0** | Severe hemodynamic compromise and biventricular strain |
  • +-----------------------+---------------------+-----------------------------------------------------------+
  • Anthropometric Weight Scalars for Drug Dosing

Total Body Weight (TBW): The patient's actual measured physical weight.

Ideal Body Weight (IBW): Estimated normal weight for height and sex (Devine Formula): IBW Men = 50 kg + 2.3 kg for each inch over 5 feet \text{IBW}_{\text{Men}} = 50 \text{ kg} + 2.3 \text{ kg for each inch over 5 feet} IBW Men ​ = 50 kg + 2.3 kg for each inch over 5 feet IBW Women = 45.5 kg + 2.3 kg for each inch over 5 feet \text{IBW}_{\text{Women}} = 45.5 \text{ kg} + 2.3 \text{ kg for each inch over 5 feet} IBW Women ​ = 45.5 kg + 2.3 kg for each inch over 5 feet

Lean Body Weight (LBW): The mass of non-fat tissues (muscle, bone, vital organs, blood volume), accounting for approximately 70 − 80 % 70 - 80\% 70 − 80% of TBW in non-obese individuals, but capped at ≈ 130 % of IBW \approx 130\% \text{ of IBW} ≈ 130% of IBW in morbid obesity (Janmahasatian formula): LBW ≈ IBW × 1.3 \text{LBW} \approx \text{IBW} \times 1.3 LBW ≈ IBW × 1.3

2. Respiratory Pathophysiology: The Bariatric Mechanics Cascade +-------------------------------------------------------------------------+

  • | BARIATRIC RESPIRATORY DYNAMICS |
  • +-------------------------------------------------------------------------+
  • | • Exponential Drop in Expiratory Reserve Volume (ERV ↓↓) |
  • | • Functional Residual Capacity (FRC ↓↓) Falls Below Closing Capacity |
  • | • Decreased Chest Wall Compliance (Excess Adipose on Thoracic Cage) |
  • | • Decreased Lung Compliance (Alveolar Atelectasis & Increased Blood Vol)|
  • | • Increased Work of Breathing (Up to 4-fold increase in O₂ cost) |
  • | • Elevated Basal O₂ Consumption (VO₂) and CO₂ Production (VCO₂) |

+-------------------------------------------------------------------------+ [FRC AND ERV REDUCTION IN MORBID OBESITY]

  • Non-Obese Healthy Adult (70 kg) Morbidly Obese Adult (140 kg)
  • +------------------------+ +------------------------+
  • | Inspiratory Capacity | | Inspiratory Capacity |
  • | (IC ≈ 3500 mL) | | (IC ≈ 2800 mL) |
  • | | | |
  • +------------------------+ +------------------------+
  • | Expiratory Res. Volume | | ERV (↓ SEVERELY ~250mL)|
  • | (ERV ≈ 1100 mL) | +------------------------+
  • +------------------------+ <--- FRC ---+ Residual Volume |
  • | Residual Volume | (↓ 50%) | (RV ≈ 1200 mL) |
  • | (RV ≈ 1200 mL) | | |
  • +------------------------+ +------------------------+
  • The Safe Apnea Time Collapse

Non-Obese Healthy Adult: Following 100 % O 2 100\% \text{ O}_2 100% O 2 ​ preoxygenation (denitrogenation), safe apnea time before S p O 2 SpO_2 Sp O 2 ​ falls below 90 % 90\% 90% is 6 − 8 minutes 6 - 8 \text{ minutes} 6 − 8 minutes .

Morbidly Obese Patient: Safe apnea time is dramatically reduced to less than 2 − 2.5 minutes 2 - 2.5 \text{ minutes} 2 − 2.5 minutes .

Mechanism: A severely compressed oxygen reservoir (depleted FRC) combined with a high rate of continuous oxygen consumption ( V O 2 VO_2 V O 2 ​ elevated due to metabolic mass of fat and increased respiratory muscle effort) causes rapid alveolar oxygen depletion.

Obstructive Sleep Apnea (OSA) vs. Obesity Hypoventilation Syndrome (OHS) +---------------------------------------------------------------------------------------------------------+

  • | OSA VS. OBESITY HYPOVENTILATION SYNDROME (OHS) |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | Feature | Obstructive Sleep Apnea (OSA) | Obesity Hypoventilation Syndrome (OHS) |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Definition** | Repetitive partial/complete upper | Triad: Obesity ($BMI > 30$), awake |
  • | | airway collapse during sleep | daytime hypercapnia, and sleep apnea |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Daytime Arterial Gas| **Normal** ($PaCO_2 < 45 \text{ mmHg}$| **Abnormal:** Daytime **$PaCO_2 > 45$** |
  • | | with normal serum $HCO_3^-$) | with elevated compensatory $HCO_3^-$ |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Ventilatory Drive** | Intact daytime central response to | **Blunted central hypercapnic drive**; |
  • | | $CO_2$; arousal breaks obstruction | relies heavily on hypoxic drive |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Cardiopulmonary** | Episodic nocturnal hypoxemia and | **Severe Pulmonary Hypertension**, RVH, |
  • | **Complications** | systemic hypertension | cor pulmonale, polycythemia, heart fail. |
  • +-----------------------+--------------------------------------+------------------------------------------+

The STOP-Bang Questionnaire for OSA Risk Stratification +-------------------------------------------------------------------------+

  • | STOP-BANG OSA ASSESSMENT TOOL |
  • +-------------------------------------------------------------------------+
  • | **S** - Snoring: Do you snore loudly (louder than talking/through door)?|
  • | **T** - Tired: Do you often feel tired, fatigued, or sleepy during day?|
  • | **O** - Observed: Has anyone observed you stop breathing during sleep? |
  • | **P** - Pressure: Do you have or are you being treated for High BP? |
  • | **B** - BMI: Is your Body Mass Index > 35 kg/m²? |
  • | **A** - Age: Are you older than 50 years of age? |
  • | **N** - Neck Circumference: Is neck > 40 cm (16 in) [>43 cm (17 in) ♂]?|
  • | **G** - Gender: Is the patient Male? |

+-------------------------------------------------------------------------+ Risk Strata: 0 − 2 = Low Risk , 3 − 4 = Intermediate Risk , ≥ 5 = High Risk for Severe OSA \text{Risk Strata: } 0 - 2 = \text{Low Risk}, \quad 3 - 4 = \text{Intermediate Risk}, \quad \mathbf{\ge 5 = \text{High Risk for Severe OSA}} Risk Strata: 0 − 2 = Low Risk , 3 − 4 = Intermediate Risk , ≥ 5 = High Risk for Severe OSA

3. Cardiovascular Pathophysiology in Morbid Obesity

Expanded Blood Volume: Although total blood volume is increased in obesity, blood volume per unit mass is lower than in lean adults (approximately 45 − 50 mL/kg 45 - 50 \text{ mL/kg} 45 − 50 mL/kg TBW compared to 70 mL/kg 70 \text{ mL/kg} 70 mL/kg in lean adults). Adipose tissue receives approximately 2 − 3 mL / 100 g / min 2 - 3 \text{ mL}/100\text{g}/\text{min} 2 − 3 mL /100 g / min of blood flow.

Cardiac Output: Increases linearly by approximately 20 − 30 mL/min 20 - 30 \text{ mL/min} 20 − 30 mL/min per kilogram of excess adipose tissue , mediated entirely through increased stroke volume (resting heart rate is typically normal or slightly elevated).

Ventricular Remodeling:

Left Ventricle: Chronic volume overload induces eccentric LV hypertrophy ; concomitant systemic hypertension induces concentric LV hypertrophy , culminating in severe diastolic and systolic dysfunction.

Right Ventricle: Chronic nocturnal obstruction, hypercapnia, and respiratory acidosis cause recurrent hypoxic pulmonary vasoconstriction (HPV), leading to irreversible pulmonary arteriolar remodeling, pulmonary arterial hypertension (PAH) , and right ventricular failure ( cor pulmonale ).

4. Anesthetic Pharmacology & Master Dosing Matrix

Administering medications in morbidly obese patients based strictly on Total Body Weight (TBW) leads to life-threatening overdoses of lipophilic anesthetics and muscle relaxants, whereas underdosing on Ideal Body Weight (IBW) can cause inadequate neuromuscular blockade or awareness under anesthesia. +---------------------------------------------------------------------------------------------------------+

  • | MASTER BARIATRIC DRUG DOSING MATRIX |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | Drug & Class | Dosing Weight | Recommended Dosing | Pharmacokinetic & Clinical Rationale |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Propofol** | **Lean Body** | 1.5 - 2.0 mg/kg LBW | Induction on TBW causes severe vaso- |
  • | (Induction) | **Weight (LBW)** | | dilation, myocardial depression & arrest|
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Propofol** | **Total Body** | 100 - 200 mcg/kg/min| High volume of distribution and |
  • | (Maintenance/TIVA) | **Weight (TBW)** | TBW | accelerated metabolic clearance in fat |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Succinylcholine** | **Total Body** | **1.0 - 1.5 mg/kg** | **Pseudocholinesterase activity and ECF |
  • | (Depolarizing NMB) | **Weight (TBW)** | **TBW** | volume increase in direct proportion to |
  • | | | | TBW; dosing on IBW risks sub-paralysis**|
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Rocuronium /** | **Ideal Body** | Intubation: | Dosing on TBW results in excessive drug |
  • | **Vecuronium /** | **Weight (IBW)** | 0.6 - 1.2 mg/kg IBW | concentration at neuromuscular junction,|
  • | **Cisatracurium** | | (Roc); 0.1 mg/kg Vec| severely prolonging duration of block |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Sugammadex** | **Total Body** | 2, 4, or 16 mg/kg | **Encapsulation requires 1:1 molecular |
  • | (NMB Reversal)** | **Weight (TBW)** | **TBW** | binding of relaxant in central & periph |
  • | | | | compartments; dosed on actual TBW** |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Neostigmine** | **Ideal Body** | 0.04 - 0.07 mg/kg | Dosed on IBW to avoid excessive cholinergic|
  • | | **Weight (IBW)** | IBW (max 5 mg) | muscarinic toxicity and bradycardia |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Fentanyl /** | **Lean Body** | Bolus: 1-2 mcg/kg | Rapid distribution into fat, but delayed|
  • | **Sufentanil** | **Weight (LBW)** | LBW; Infusion on LBW| elimination causes accumulation & apnea |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Remifentanil** | **Lean Body** | 0.05 - 0.2 mcg/kg/ | Rapidly cleared by non-specific blood/ |
  • | | **Weight (LBW)** | min LBW | tissue esterases; does not accumulate |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • | **Desflurane** | Inhalational | Titrate to MAC | **Lowest blood-gas (0.42) & fat-gas |
  • | | | | solubility; fastest, most predictable |
  • | | | | emergence in bariatric surgery** |
  • +---------------------+-------------------+---------------------+-----------------------------------------+
  • 5. Airway Management, Positioning & Ventilatory Strategy
  • The Ramped / HELP Position

In the supine position, excess adipose tissue on the upper back, shoulders, posterior neck, and chest forces the head into deep flexion, severely obscuring the line of sight during direct or video laryngoscopy.

Head-Elevated Laryngoscopy Position (HELP / Ramped Position):

Elevate the upper torso, shoulders, head, and neck using folded blankets, foam ramps, or motorized table adjustments.

The Gold Standard Alignment Landmark: An imaginary horizontal line must connect the sternal notch directly with the external auditory meatus (tragus of the ear) .

This alignment opens the pharyngeal axis, improves mask ventilation mechanics, aligns the visual line of sight with the laryngeal inlet, and expands chest excursion. [THE RAMPED / HELP POSITION]

  • [Tragus / External Auditory Meatus]
  • o . . . . . . . . . . . . [Sternal Notch]
  • / \ |
  • / \ |
  • / \========[ Ramp / Elevation ] v
  • / ================
  • [Head & Neck Elevated] [Horizontal Plane]
  • Preoxygenation & Induction Technique

25° - 30° Head-Up Position: Increases FRC by removing the weight of the abdominal pannus from the diaphragm.

CPAP / PEEP Preoxygenation: Applying 5 − 10 cmH 2 O 5 - 10 \text{ cmH}_2\text{O} 5 − 10 cmH 2 ​ O CPAP via a tight mask seal during 3 − 5 minutes 3 - 5 \text{ minutes} 3 − 5 minutes of tidal breathing with 100 % O 2 100\% \text{ O}_2 100% O 2 ​ prevents atelectasis and extends safe apnea time by up to 50 % 50\% 50% .

Video Laryngoscopy (VL): Strongly recommended as the primary first-line intubation device for morbidly obese patients.

Intraoperative Lung-Protective Mechanical Ventilation

Tidal Volume ( V T V_T V T ​ ): Must be calculated strictly based on Ideal Body Weight (IBW) at 6 − 8 mL/kg IBW 6 - 8 \text{ mL/kg IBW} 6 − 8 mL/kg IBW (NEVER Total Body Weight, which causes severe volutrauma and barotrauma).

PEEP: Apply 8 − 12 cmH 2 O 8 - 12 \text{ cmH}_2\text{O} 8 − 12 cmH 2 ​ O PEEP to maintain patency of dependent alveoli.

Alveolar Recruitment Maneuvers: Intermittent sustained inflations ( 30 − 40 cmH 2 O 30 - 40 \text{ cmH}_2\text{O} 30 − 40 cmH 2 ​ O for 10 − 15 seconds 10 - 15 \text{ seconds} 10 − 15 seconds ) re-expand atelectatic lung units, followed immediately by restoration of adequate PEEP.

Driving Pressure ( P p l a t − PEEP P_{plat} - \text{PEEP} P pl a t ​ − PEEP ): Maintain < 15 cmH 2 O <15 \text{ cmH}_2\text{O} < 15 cmH 2 ​ O and maintain plateau pressure ( P p l a t P_{plat} P pl a t ​ ) < 30 cmH 2 O <30 \text{ cmH}_2\text{O} < 30 cmH 2 ​ O .

Emergence & Extubation Protocol

Full Neuromuscular Reversal: Confirm quantitative train-of-four ratio TOF ≥ 0.90 \text{TOF} \ge 0.90 TOF ≥ 0.90 (preferably using Sugammadex dosed on TBW).

Positioning: Extubate in the reverse Trendelenburg (30° - 45° head-up) or fully seated position.

Awake Criteria: Patient must be completely awake, responsive to commands, with return of protective airway reflexes and regular spontaneous tidal volumes.

Loading diagram... Bariatric Perioperative Airway, Dosing & Ventilatory Optimization Algorithm